In PD mouse models, treatment with resveratrol and the polyphenol Epigallocatechin gallate (ECGC), results in the protection against toxicity through an up-regulation of PGC-1α, via SIRT1 activity (Xu et al., 2018). The gene discussed is SIRT1; the disease is Parkinson disease.